Q&A With FDA Commissioner Robert Califf
JAMA Author Interviews
00:00
The State of the Evidence Generation System
During the pandemic, we had thousands of clinical trials that were started. The vast majority of us studies either never finished or didn't answer an important question. We have to figure out when there are important questions to public health and reward investigators for participating. And trim down all the unnecessary bureaucracy to make sure we get the answer as quickly and as definitively as possible.
Transcript
Play full episode
